Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stages of Infection

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

RodA promotes intestinal colonization by group B <i>Streptococcus</i>.

Infection and immunity·2026

Same author

Epidemiologic characteristics of invasive group B streptococcal infections caused by rare serotypes among adults in the United States, 2007-2023.

PLOS global public health·2026

Same author

Molecular Relatedness of Maternal and Neonatal Multidrug-Resistant Gram-Negative Colonization Isolates in Low- and Middle-Income Countries: A Systematic Review.

Open forum infectious diseases·2026

Same author

RodA Promotes Intestinal Colonization by Group B <i>Streptococcus</i>.

bioRxiv : the preprint server for biology·2025

Same author

Expansion of the Group B <i>Streptococcus</i> serotype repertoire via gene acquisition from other streptococcal species.

Microbiology spectrum·2025

Same author

Haemophilus influenzae Type b Meningitis in Infants, New York, New York, USA, 2022-2023.

Emerging infectious diseases·2025

Same journal

Clinical progress note: Influenza.

Journal of hospital medicine·2026

Same journal

Clinical progress note: Rotavirus.

Journal of hospital medicine·2026

Same journal

Breaking the bottleneck: A resident-run initiative to advance care for emergency department patients awaiting medicine admission.

Journal of hospital medicine·2026

Same journal

The impact of private equity acquisition of US hospitals on patient outcomes: A systematic review.

Journal of hospital medicine·2026

Same journal

Association of facility- and hospital medicine group-level characteristics on the impact of burnout among hospitalists in the Veteran's Health Administration.

Journal of hospital medicine·2026

Same journal

Safety steps: A framework for promoting safe trainee autonomy in clinical emergencies.

Journal of hospital medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 15, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Clinical progress note: Haemophilus influenzae type b.

Anne Ewing¹, Sydney Haldeman¹, Adam J Ratner²

¹Department of Pediatrics, NYU Grossman School of Medicine, New York, New York, USA.

Journal of Hospital Medicine

|April 10, 2025

Summary

This summary is machine-generated.

Haemophilus influenzae type b (Hib) infections are rare but pose risks for immunocompromised individuals. Prompt recognition, management, and vaccination are crucial for prevention in clinical settings.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Experiment Videos

Last Updated: May 15, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Area of Science:

Infectious Diseases
Immunology
Public Health

Background:

Vaccine-preventable diseases require ongoing clinical review.
Haemophilus influenzae type b (Hib) historically caused significant pediatric meningitis.
Hib now causes rare invasive disease, particularly in at-risk populations.

Purpose of the Study:

To review the current clinical relevance of Haemophilus influenzae type b (Hib).
To highlight at-risk patient populations for invasive Hib disease.
To emphasize crucial management and prevention strategies for hospitalists.

Main Methods:

Review of historical and current data on Hib epidemiology.
Identification of patient risk factors for invasive Hib disease.
Discussion of clinical management and prevention protocols.

Main Results:

Hib remains a concern, especially for patients with immunodeficiency or complement deficiencies (e.g., sickle cell disease, asplenia).
Prompt recognition and management are vital for improving outcomes.
Inpatient vaccination and education are key preventive measures.

Conclusions:

Hospitalists play a critical role in managing and preventing Hib disease.
Vigilance for Hib is necessary, particularly in vulnerable populations.
Effective vaccination strategies are essential for controlling vaccine-preventable diseases.